More on OCGN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/3/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Ocugen (NQ:OCGN)
Delayed: 1.61 -0.13 (7.47%)
Prev. Close $1.74  
Open$1.74 
52 Wk High$ 
52 Wk Low$ 
Day High$1.77 
Day Low$1.60 
P/E N/A  
EPS$ 
Volume5,627,959 

Friends, Peers and Foes (?): CARM (more...)

Mar 5, 2026 09:28 AM Form 3 Ocugen, Inc. For: Mar 04 Filed by: Johnson-Greene Treerita Essalima
Mar 4, 2026 12:24 PM Form S-8 Ocugen, Inc.
Mar 4, 2026 11:38 AM Form 10-K Ocugen, Inc. For: Dec 31
Mar 4, 2026 11:12 AM Form 8-K Ocugen, Inc. For: Mar 04
Mar 4, 2026 11:08 AM Form 8-K Ocugen, Inc. For: Mar 04
Mar 4, 2026 08:19 AM Ocugen (OCGN) Reports In-Line Q4 EPS
Mar 4, 2026 08:15 AM Ocugen completes Phase 3 enrollment for retinitis pigmentosa gene therapy
Mar 4, 2026 08:15 AM Ocugen Provides Business Update with Fourth Quarter and Full Year 2025 Financial Results
Mar 2, 2026 07:02 AM Ocugen completes enrollment for phase 3 retinitis pigmentosa trial
Mar 2, 2026 07:02 AM Ocugen Announces Phase 3 liMeliGhT Enrollment Completion for OCU400, a Novel Modifier Gene Therapy for Broad Retinitis Pigmentosa
View All Articles

Entities mentioned with OCGN

View All Entities